University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
- Rutgers researchers: How Meta turned teen attention into a public health crisis.
- Kids under 5 are grabbing their parents’ vapes and getting sick at record levels, researchers say.
- These N.J. medical schools are among some of the best in the country. See how they rank.
- Estrogen Patch Shortages Are Ongoing—Here’s Where to Find Them and What to Ask Your Doctor.
Categories
- Community (2,497)
- Covid (1,001)
- CTO Events (6)
- News (3,170)
- Pilots (21)